Since the beginning of 2023, and as of 2 October 2023, two MERS-CoV cases have been reported with the date of onset in 2023 by United Arab Emirates (1) and Saudi Arabia (1).
Since the beginning of 2023, and as of 4 September 2023, two MERS-CoV cases have been reported with the date of onset in 2023 by United Arab Emirates (1) and Saudi Arabia (1)
As autumn moves to winter, the WHO/Europe, EC and ECDC are issuing a clear, urgent message: people who remain unprotected against both COVID-19 and seasonal influenza – especially the most vulnerable and at-risk – should take up any offer for vaccination to prevent or mitigate the impact of these co-circulating respiratory infections.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1 - 7 October 2023 and includes updates on dengue, West Nile virus disease, COVID-19, chikungunya, Middle East respiratory syndrome, mpox, and mass gathering monitoring for the Rugby World Cup.
This document presents the core protocol for ECDC studies of CVE and IVE against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection, respectively, at primary care level.